期刊文献+

奎的平与氯氮平对脑电图影响的对照观察

A contrast observation of quetiapine and clozapine in affecting electroencephalogram
下载PDF
导出
摘要 目的探讨奎的平与氯氮平对脑电图的影响及差异性。方法符号CCMD-2-R诊断的精神分裂症患者130例,服用奎的平、氯氮平治疗各65例,分别于服药后2周、4周、6周进行脑电图检测,采用阳性与阴性症状量表(PANSS)观察疗效。结果奎的平组脑电图异常率29.2%,氯氮平组脑电图异常率80%,两组比较差异具有显著性意义(P<0.01),两组药物脑电图异常改变率与临床疗效无关。结论奎的平可引起脑电图异常改变,但其异常程度显著低于氯氮平。 Objective To explore that quetiapine and clozapine made the differences to electroencephalogram respectively. Methods 130 patients who met the CCMD-2-R criteria for schizophrenia were divided into two equal groups treated with quetiapine and clozapine respectively,monitored with electroencephalogram, observed the curative effects with PANSS after the second and the forth and the sixth week respectively. Results The abnormal electroencephalogram incidence was 29% in quetiapine group, and 80% in clozapine group (P 〈 0. 01 ). The abnormal electroencephalogram changes caused by quetiapine and clozapine did not relate to the clinical curative effects. Conclusion Quetiapine was able to cause the abnormal electroencephalogram changes,but they were inferior to that of clozapine.
作者 袁凤娟
出处 《中国现代药物应用》 2008年第6期24-25,共2页 Chinese Journal of Modern Drug Application
关键词 精神分裂症 奎的平 氯氮平 脑电图 Schizophrenia Quetiapine Clozapine Electroencephalogram
  • 相关文献

参考文献3

二级参考文献15

  • 1[1]Goldstein JM. Atypical antipsychotic drugs :beyond acute psychosis, new directions. Emerging Drugs, 1999,4:127
  • 2[2]Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry,1997,54:549
  • 3[3]Borison RL, Arvanitis LA, Miller BG. ICI 204.636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US Seroquel Study Group. J Clin Psychopharmacol, 1996,16:158
  • 4[4]Arvanitis LA,Miller BG and the Seroquel Trial 13 Group.Multiple fixed doses of "Seroquel"(quetiapine) in patients with acute exacerbation of schizophrenia:a comparison with haloperiadaol and placebo.Biol Psychiatry,1997,42:233
  • 5[5]Beasley CM,Sanger T,Satterlee W,et al.Olanzapine versus placebo:results of double-blind,fixed dose olanzapine trail.Psychopharmacology,1996,124:159
  • 6[6]Tran PV,Hamilton SH,Kuntz AJ,et al.Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.J Clin Psychopharmacol,1997,17:407
  • 7[7]Kasper S,Muller-Spahn F.Review of quetiapine and its clinical applications in schizophrenia.Exp Opin Pharmacother,2000,1:783
  • 8[8]Purdon S,Malla A,Labelle A,et al.Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.J Psychiatr Neurosci,2001,26:137
  • 9[9]Hellwell J,Mckeller M,Raniwalla J."Seroquel":efficacy in aggression,hostility and low mood of schizophrenia [abstract].Presented at the CINP Congress,1998,Glasgow UK
  • 10[10]Tariot PH,Salzman MD,Yeung PP,et al.Long-term use of quetiapine in elderly patients with psychotic disorders.Clin Ther,2000,22:1068

共引文献166

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部